Literature DB >> 7678580

Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain.

A Hill1, M Takiguchi, A McMichael.   

Abstract

Assembly of HLA class I molecules was studied using pulse-chase labeling of B-lymphoblastoid cell lines with 35S-methionine, immunoprecipitation with antibodies detecting free or beta 2-microglobulin-associated heavy chain and isoelectric focusing. Marked differences between the products of different class I alleles were noted. HLA-B51 assembled very inefficiently, with considerable free heavy chain still detected in an unsialated form after a four hour chase. The closely related molecule HLA-B35 was in contrast rapidly assembled, all newly synthesized heavy chain being detected in a beta 2m-associated sialated form within 30 minutes. Analysis of naturally occurring variants related to HLA-B35 and HLA-B51 localized the region determining assembly efficiency to the alpha 2 domain, in which these molecules differ at eight amino acid residues. The effect was not due to a linked dominant gene, as both patterns of assembly were observed in a single cell line.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678580     DOI: 10.1007/bf00216831

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  41 in total

Review 1.  Evolution of class-I MHC genes and proteins: from natural selection to thymic selection.

Authors:  D A Lawlor; J Zemmour; P D Ennis; P Parham
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

Authors:  J J Neefjes; B S Breur-Vriesendorp; G A van Seventer; P Iványi; H L Ploegh
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

3.  The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.

Authors:  T Ooba; H Hayashi; S Karaki; M Tanabe; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules.

Authors:  B P Chen; V Lam; E E Kraus; R DeMars; P M Sondel
Journal:  Hum Immunol       Date:  1989-10       Impact factor: 2.850

5.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

Authors:  N J Stam; H Spits; H L Ploegh
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

6.  Slower processing, weaker beta 2-M association, and lower surface expression of H-2Ld are influenced by its amino terminus.

Authors:  J C Beck; T H Hansen; S E Cullen; D R Lee
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

7.  Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association.

Authors:  J J Neefjes; H L Ploegh
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

8.  A biological role for the major histocompatibility antigens.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

9.  E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins.

Authors:  W A Jefferies; H G Burgert
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.

Authors:  A J McMichael; F M Gotch; J Rothbard
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  12 in total

1.  Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket.

Authors:  A Kikuchi; T Sakaguchi; K Miwa; Y Takamiya; H G Rammensee; Y Kaneko; M Takiguchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; E J Wiertz; L Sun; K N Fish; J A Nelson; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 3.  Genetics of ankylosing spondylitis--insights into pathogenesis.

Authors:  Matthew A Brown; Tony Kenna; B Paul Wordsworth
Journal:  Nat Rev Rheumatol       Date:  2015-10-06       Impact factor: 20.543

4.  Distinct assembly profiles of HLA-B molecules.

Authors:  Syed Monem Rizvi; Nasir Salam; Jie Geng; Ying Qi; Jay H Bream; Priya Duggal; Shehnaz K Hussain; Jeremy Martinson; Steven M Wolinsky; Mary Carrington; Malini Raghavan
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

Review 5.  Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27.

Authors:  R A Colbert; S Prahalad
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

6.  Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.

Authors:  T R Jones; L Sun
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression.

Authors:  A E Campbell; J S Slater
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 8.  T cell receptor usage in infectious disease.

Authors:  M F Callan; A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1999

9.  The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion.

Authors:  D G Kavanagh; M C Gold; M Wagner; U H Koszinowski; A B Hill
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

10.  Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

Authors:  J A McCutcheon; J Gumperz; K D Smith; C T Lutz; P Parham
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.